北美遗传性视网膜疾病市场 – 行业趋势和 2029 年预测

市场分析和见解：北美遗传性视网膜疾病市场

遗传性视网膜疾病（IRD）是一组可能导致严重视力丧失甚至失明的疾病。每个 IRD 都由至少一个基因无法正常工作引起。IRD 会影响所有年龄段的人，进展速度不同，而且很少见。然而，许多 IRD 是退行性的，这意味着疾病的症状会随着时间的推移而恶化。常见的 IRD 类型包括莱伯先天性黑蒙 (LCA)、视网膜色素变性、脉络膜白斑、斯塔加特病和全色盲。基因治疗的目标是纠正或补偿有缺陷的基因。由于视网膜具有独特的物理构造，IRD 是基因治疗的强有力候选者。与身体的其他器官相比，眼睛很小，易于进行治疗。然而，身体的某些部位具有免疫特权，这意味着正常的免疫反应不那么活跃。这通常发生在我们身体非常重要的部位，如果出现肿胀或炎症，可能会受损。这意味着植入眼睛的任何东西（例如带有修正基因的细胞）都不太可能被排斥。

遗传性视网膜疾病的诊断和治疗包括各种技术，这些技术允许在产品获批后诊断遗传性视网膜疾病。该疾病的治疗方法最近获得批准，这支持了市场的增长。

遗传性视网膜疾病具有支持作用，旨在减少疾病的进展。Data Bridge Market Research 分析，遗传性视网膜疾病市场在 2022 年至 2029 年的预测期内将以 7.6% 的复合年增长率增长。

遗传性视网膜疾病市场动态

驱动程序

• 遗传性视网膜疾病患病率上升

遗传性致突变位点的日益流行和不断发现有望成为市场增长的驱动力。单基因IRD 的流行率约为 1/2000，影响 200 万在线用户。

• 管道产品不断增加

随着临床试验活动上升到新的水平，该领域似乎有望在 IRD 研究和患者护理方面取得快速而重要的进展。这些只是一些常见的试验，因此，在这个市场运营的公司不断进行临床试验，并将他们的候选人纳入临床试验。这有望创造机会并推动北美遗传性视网膜疾病市场的发展。遗传病患病率高

此外，米勒-迪克综合征、沃克-沃堡综合征等一些遗传病发病率的上升将进一步促进遗传性视网膜疾病市场的增长。

此外，主要参与者的战略举措增多、医疗技术的进步、IRD 产品审批的增加、公共和私人组织提高认识的举措增多以及政府资金的增加都是扩大遗传性视网膜疾病市场的因素。其他因素，如对有效疗法的需求增加和早期遗传咨询的采用率上升，将对遗传性视网膜疾病市场的增长率产生积极影响。此外，高可支配收入、各种视网膜疾病病例数的增加将导致遗传性视网膜疾病市场的扩大。 

机会

• 政府针对遗传性视网膜疾病的治疗举措增多。

此外，认知度和治疗寻求率的提高以及新兴的治疗报销政策将为市场增长率带来新的机会。

此外，有效疗法的推出和持续的临床试验将为 2022-2029 年预测期内的遗传性视网膜疾病市场提供有利的机会。此外，当前治疗的巨大未满足需求和医疗技术的发展将在未来提高遗传性视网膜疾病市场的增长率。

限制/挑战

However, high cost associated with the available treatment and lack of infrastructure in low-income countries will impede the growth rate of inherited retinal diseases market. Additionally, lack of enough qualified professionals, and complications involved with the disease will hinder the inherited retinal diseases market growth.

This inherited retinal diseases market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Inherited retinal diseases market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Inherited retinal disease is a genetic disorder that is relatively uncommon and whose incidence is unknown. According to a study of inherited retinal diseases the prevalence of IRD’s is 1 in 3000.

Retinitis pigmentosa is the most common disorder among the other disorders. Retinitis pigmentosa is a group of related eye disorders caused by variations in 60 genes that affect the retina. IRDs are a heterogeneous group of orphan eye diseases with a prevalence estimated at between 0.06% and 0.2%, with a North America IRD caseload in the range of 5–10 million individuals.

Inherited retinal diseases market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Post COVID-19 Impact on Inherited Retinal Diseases Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in anticonvulsant medication adherence during the pandemic.

Recent Development

• In January 2022, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Diana Davis Spencer Foundation Enhanced Translational Research Acceleration Program.

North America Inherited Retinal Diseases Market Scope

The inherited retinal diseases market is segmented into disease type, type, end-user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Disease Type

• Retinitis Pigmentosa
•  Stargardt’s Disease 
•  Achromatopsia
•  Cone-Rod Dystrophy
•  Choroideremia
•  Leber Congenital Amaurosis (LCA)  
•  Macular Edema
•  Others

On the basis of type, the inherited retinal diseases market is segmented into disease type (retinitis pigmentosa, stargardt’s disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others

Type

• Diagnosis
• Therapy

On the basis of type, the inherited retinal diseases market is segmented into diagnosis and therapy. The diagnosis segment is sub-segmented into gene therapy, retinal prosthetic, neuroprotective agents, others. The neuroprotective agents are further sub-segmented into vitamin A palmitate, docosahexaenoic acid (DHA), lutein, others. The diagnosis segment is segmented into clinical diagnosis and genetic diagnosis. Clinical diagnosis is further sub-segmented into retinal imaging, electrophysiological tests, visual field test and clinical eye examination. Retinal imaging is further segmented into optical coherence tomography (OCT), fundus autofluorescence imaging (FAF), scanning laser ophthalmoscopy (SLO), adaptive optics (AO) imaging and conventional color fundus imaging. Electrophysiological tests are further segmented into full-field electroretinogram (ERG) and dark adaptometry (DA). Visual field test is further segmented into computerized visual field tests and manual field test. Clinical Eye examination is segmented into slit lamp, indirect ophthalmoscopy, refraction test, dilation exam

End User

• Hospitals
• Specialty Clinics
• Ambulatory surgical center
• Home Healthcare
• Others

On the basis of end-users, the inherited retinal diseases market is segmented into hospitals, specialty clinics, ambulatory surgical center, home healthcare and others

Distribution Channel

• Retail Sales
• Direct Tender

The inherited retinal diseases market is also segmented on the basis of distribution channel into retail sales, direct tender.

Pipeline Analysis

The pipeline analysis of inherited retinal diseases drugs includes various pipeline therapies such as NCT05244304, NCT00999609, NCT05176717, NCT05158296, NCT04850118. Belite Bio, Inc, Spark Therapeutics, ProQR Therapeutics, Applied Genetic Technologies Corp, Biogen, MeiraGTx Ltd are involved in the development of potential drugs for the improvement of treatment of seizures.

Inherited Retinal Diseases Market Regional Analysis/Insights

The inherited retinal diseases market is analysed and market size insights and trends are provided by country, disease type, type, end-user and distribution channel as referenced above.

The countries covered in the inherited retinal diseases market report are U.S., Canada and Mexico in North America.

U.S. dominates the inherited retinal diseases market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Inherited Retinal Diseases Market Share Analysis

The inherited retinal diseases market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on inherited retinal diseases market.

Some of the major players operating in the inherited retinal diseases market are Spark Therapeutics, Novartis AG, Okuvision, Nidek Co. Ltd., Invitae Corporation, Carl Zeiss Meditech AG, Optos (A Subdidiary of Nikon Corporation, Neurosoft, PIXIUM VISION, LKC TECHNOLOGIES, INC., Renurone, Astellas Pharma, REGENXBIO Inc., Ionis Pharmaceutics, Sparing Vision, Ocugen Inc, Johnson & Johnson,  IVERIC bio, Second Sight, Coave Therapeutics, MeiraGTx Limited, Gensight Biologics, ProQR Therapeutics, Bionic Vision Technologies among others.

Research Methodology: North America Inherited Retinal Diseases Market

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、北美与地区和供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-67950